Eindhoven, Netherlands

Ewald T J Van Den Bremer

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Genmab A+s, Genmag A/s. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ewald T J Van Den Bremer. Retrieved from https://idiyas.com/inventor/ewald-t-j-van-den-bremer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 165(Granted Patents)


Location History:

  • Best, NL (2015)
  • Eindhoven, NL (2019 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Ewald T J Van Den Bremer

Introduction: Ewald T J Van Den Bremer is a prominent inventor based in Eindhoven, Netherlands. With a robust portfolio of six patents, he has made significant contributions to the field of biotechnology, particularly in the development of novel antibody-based therapeutics.

Latest Patents: Among his latest innovations are groundbreaking patents related to heterodimeric antibody Fc-containing proteins. These include methods for producing novel bispecific antibodies and heterodimeric proteins. His work focuses on offering innovative production techniques that enhance therapeutic efficacy and expand treatment options in medical science.

Career Highlights: Ewald has played a pivotal role in the biotechnology sector, having worked with companies such as Genmab A/S and Genmag A/S. His expertise in antibody technologies has positioned him as a key figure in the advancement of biologics and therapeutic proteins.

Collaborations: Throughout his career, Ewald has collaborated with noteworthy professionals such as Patrick Van Berkel and Paul Parren. These collaborations have been integral to his research and development efforts in the field of antibody-based therapeutics.

Conclusion: Ewald T J Van Den Bremer's inventive spirit and his dedication to advancing biotechnology through his patents mark him as an influential figure in the industry. His continued work promises to pave the way for new innovations in antibody therapeutics, ultimately benefiting patients and the medical community alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…